10.27.26 -- From Pre-Filled Syringes To Commercial Fill-Finish Success

Discover how predictive in silico modelling helps uncover molecular liabilities, assess developability risks, and guide formulation strategies before laboratory testing begins. Learn how early insights can reduce development risk and support more informed decisions throughout biologics development. Read the article.

Within the past few decades, there has been a steady increase in the use of pre-filled syringes (PFS) for parenteral administration of biologics, biosimilars, and other drugs.

Grade A isolators and sterilization protect delicate biologics. Precision container closures maintain integrity down to -80°C, ensuring full compliance across clinical fill-and-finish workflows.

Here, Michael Dunn outlines our current available capacity, including RABS operations, alongside the commissioning of a new Annex 1–compliant isolator filling line and expanded QC capabilities to ensure reliable, scalable execution.

A U.S.-based contract development and manufacturing organization specializing in sterile injectables, delivering high-quality development and manufacturing services without disruption.

Here, we walk you through our groundbreaking, enzymatic DNA manufacturing process that enables the production of linear DNA templates for IVT mRNA synthesis — without the use of cells.

Drive compliance, sterility assurance, and manufacturing efficiency by leveraging the proven advantages of terminal sterilization for your drug products.

Uncover how comprehensive drug product fill and finish services streamline the journey from formulation development to commercialization, ensuring quality and compliance at every stage.